Literature DB >> 25376068

Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update.

Evelyn Lo, Lindsay E Nicolle, Susan E Coffin, Carolyn Gould, Lisa L Maragakis, Jennifer Meddings, David A Pegues, Ann Marie Pettis, Sanjay Saint, Deborah S Yokoe.   

Abstract

Entities:  

Year:  2014        PMID： 25376068

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  19 in total

1.  Spinal Cord Injury Creates Unique Challenges in Diagnosis and Management of Catheter-Associated Urinary Tract Infection.

Authors:  Felicia Skelton-Dudley; James Doan; Katie Suda; S Ann Holmes; Charlesnika Evans; Barbara Trautner
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 2.  Device Utilization Ratios in Infection Prevention: Process or Outcome Measure?

Authors:  Jessica I Abrantes-Figueiredo; Jack W Ross; David B Banach
Journal:  Curr Infect Dis Rep       Date:  2018-03-23       Impact factor: 3.725

3.  The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study.

Authors:  Khalid Al Sulaiman; Nouf Al Qahtani; Mashael Al Muqrin; Maram Al Dossari; Ali Al Wabel; Tareq Al Sulaiman; Ramesh Vishwakarma; Abdulaziz Alolayan; Fatimah Abudayah; Ghazwa B Korayem; Ohoud Aljuhani
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

4.  TWOC around the clock: a multimodal approach to improving catheter care.

Authors:  Carolyn H Dawson; Melanie Gallo; Kate Prevc
Journal:  J Infect Prev       Date:  2016-11-01

5.  Impact of a hospital-wide huddle on device utilisation and infection rates: a community hospital's journey to zero.

Authors:  Alfredo J Mena Lora; Mirza Ali; Candice Krill; Sherrie Spencer; Eden Takhsh; Susan C Bleasdale
Journal:  J Infect Prev       Date:  2020-07-21

6.  Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.

Authors:  Teresa L Kauf; Vimalanand S Prabhu; Goran Medic; Rebekah H Borse; Benjamin Miller; Jennifer Gaultney; Shuvayu S Sen; Anirban Basu
Journal:  BMC Infect Dis       Date:  2017-04-28       Impact factor: 3.090

7.  A fast and frugal algorithm to strengthen diagnosis and treatment decisions for catheter-associated bacteriuria.

Authors:  Aanand D Naik; Felicia Skelton; Amber B Amspoker; Russell A Glasgow; Barbara W Trautner
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

8.  Validation and Extrapolation of a Multimodal Infection Prevention and Control Intervention on Carbapenem-Resistant Klebsiella pneumoniae in an Epidemic Region: A Historical Control Quasi-Experimental Study.

Authors:  Yunqi Dai; Tianjiao Meng; Xiaoli Wang; Bin Tang; Feng Wang; Ying Du; Yuzhen Qiu; Jialin Liu; Ruoming Tan; Hongping Qu
Journal:  Front Med (Lausanne)       Date:  2021-07-07

Review 9.  Patient and Family Engagement in Catheter-Associated Urinary Tract Infection (CAUTI) Prevention: A Systematic Review.

Authors:  Sabrina Mangal; Anthony Pho; Adriana Arcia; Eileen Carter
Journal:  Jt Comm J Qual Patient Saf       Date:  2021-05-31

Review 10.  Adhesive Pili in UTI Pathogenesis and Drug Development.

Authors:  Caitlin N Spaulding; Scott J Hultgren
Journal:  Pathogens       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.